References
- Adinolfi E, Melchiorri L, Falzoni S, Chiozzi P, Morelli A, Tieghi A, et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002; 99: 706–708
- Wiley J S, Dao-Ung L P, Gu B J, Sluyter R, Shemon A N, Li C, et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359: 1114–1119
- Thunberg U, Tobin G, Johnson A, Soderberg O, Padyukov L, Hultdin M, et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002; 360: 1935–1939
- Dao-Ung L P, Fuller S J, Sluyter R, SkarRatt K K, Thunberg U, Tobin G, et al. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. British Journal of Haematology 2004; 125: 815–816
- Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Hoy T, et al. The P2X7 receptor gene polymorphism 1513A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine or Bcl-2 family protein expression in B-cell chronic lymphocytic leukaemia. British Journal of Haematology 2003; 123: 66–71
- Nuckel H, Frey U H, Durig J, Duhrsen U, Siffert W. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. European Journal of Haematology 2004; 72: 259–263
- Zhang L Y, Ibbotson R E, Orchard J A, Gardiner A C, Seear R V, Chase A J, et al. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia 2003; 17: 2097–2100
- Sellick G S, Rudd M, Eve P, Allinson R, Matutes E, Catovsky D, Houlston R S. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia. Cancer Epidemiology Biomarkers Prevention 2004; 13: 1065–1067
- Gu B J, Zhang W, Worthington R A, Sluyter R, Dao-Ung P, Petrou S, et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. Journal of Biological Chemistry 2001; 276: 11135–11142
- Gu B J, Sluyter R, Skarratt K K, Shemon A N, Dao-Ung L P, Fuller S J, et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. Journal of Biological Chemistry 2004; 279: 31287–31295
- Skarratt K K, Fuller S J, Sluyter R, Dao-Ung L P, Gu B J, Wiley J S. A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1 – 2% of the Caucasian population. FEBS Letters 2005; 579: 2675–2678
- Campbell M J, Julious S A, Altman D G. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311: 1145–1148